Cowen Inc’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
$62.7M Buy
678,108
+635,958
+1,509% +$60.4M 4.51% 4
2019
Q1
$3.98M Buy
42,150
+37,100
+735% +$3.24M 0.43% 48
2018
Q4
$324K Sell
5,050
-3,850
-43% -$284K 0.04% 197
2018
Q3
$796K Hold
8,900
0.07% 159
2018
Q2
$707 Buy
+8,900
New +$739K 0.03% 240
2016
Q1
Sell
-4,000
Closed -$479K 421
2015
Q4
$479K Hold
4,000
0.03% 196
2015
Q3
$433K Buy
4,000
+2,248
+128% +$279K 0.03% 178
2015
Q2
$203K Hold
1,752
0.01% 371
2015
Q1
$202K Buy
+1,752
New +$209K 0.02% 343

Other funds holding CELG

Cowen Inc's CELG Position: Q2 2019 in Review

Cowen Inc increased its Celgene Corp (CELG) stake by 1,509% in Q2 2019, buying an estimated $60.4M and bringing the position to 678,108 shares worth $62.7M. The position accounts for 4.51% of the portfolio, ranked #4.

Cowen Inc first reported a position in CELG in Q1 2015 and has held it in 9 quarters since. 1,288 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Cowen Inc held 678,108 shares of Celgene Corp worth $62.7M as of Q2 2019.
  • Cowen Inc bought 635,958 Celgene Corp shares in Q2 2019, an estimated $60.4M.
  • Celgene Corp made up 4.51% of Cowen Inc's portfolio in Q2 2019, its #4 holding.
  • Cowen Inc first reported a position in Celgene Corp in Q1 2015 and has held it in 9 quarters since.
  • 1,288 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.